id,content,title,publisher,url,publishedAt,symbols,description
f9dae88b-368c-3ff9-85df-d9e11c2f9705,"{'id': 'f9dae88b-368c-3ff9-85df-d9e11c2f9705', 'contentType': 'STORY', 'title': 'Fortress Biotech Gets US FDA Letter for Deficiencies at Manufacturing Site; Stock Down 30% Premarket', 'description': '', 'summary': 'Fortress Biotech (FBIO) and its Cyprium Therapeutics unit said Wednesday that the US Food and Drug A', 'pubDate': '2025-10-01T13:02:52Z', 'displayTime': '2025-10-01T13:02:52Z', 'isHosted': True, 'bypassModal': False, 'previewUrl': None, 'thumbnail': None, 'provider': {'displayName': 'MT Newswires', 'url': 'https://www.mtnewswires.com/'}, 'canonicalUrl': {'url': 'https://finance.yahoo.com/news/fortress-biotech-gets-us-fda-130252526.html', 'site': 'finance', 'region': 'US', 'lang': 'en-US'}, 'clickThroughUrl': {'url': 'https://finance.yahoo.com/news/fortress-biotech-gets-us-fda-130252526.html', 'site': 'finance', 'region': 'US', 'lang': 'en-US'}, 'metadata': {'editorsPick': False}, 'finance': {'premiumFinance': {'isPremiumNews': True, 'isPremiumFreeNews': False}}, 'storyline': None}",N/A,N/A,N/A,N/A,N/A,N/A
f0addc2e-7adf-3aa5-916e-add7cac83350,"{'id': 'f0addc2e-7adf-3aa5-916e-add7cac83350', 'contentType': 'STORY', 'title': ""Owning 75% inZydus Lifesciences Limited (NSE:ZYDUSLIFE) means that insiders are heavily invested in the company's future"", 'description': '', 'summary': ""Key Insights Insiders appear to have a vested interest in Zydus Lifesciences' growth, as seen by their sizeable ownership 75% of the company is held by a single shareholder (Pankaj Patel) Institutional ownership in Zydus Lifesciences is 14%"", 'pubDate': '2024-11-13T01:06:50Z', 'displayTime': '2024-11-13T01:06:50Z', 'isHosted': True, 'bypassModal': False, 'previewUrl': None, 'thumbnail': {'originalUrl': 'https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316', 'originalWidth': 1194, 'originalHeight': 432, 'caption': '', 'resolutions': [{'url': 'https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316', 'width': 1194, 'height': 432, 'tag': 'original'}, {'url': 'https://s.yimg.com/uu/api/res/1.2/hEYH.lZROAe2G_yFC8lOdg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316', 'width': 170, 'height': 128, 'tag': '170x128'}]}, 'provider': {'displayName': 'Simply Wall St.', 'url': 'https://simplywall.st/'}, 'canonicalUrl': {'url': 'https://finance.yahoo.com/news/zydus-lifesciences-nsei-zyduslife-reports-010650605.html', 'site': 'finance', 'region': 'US', 'lang': 'en-US'}, 'clickThroughUrl': {'url': 'https://finance.yahoo.com/news/zydus-lifesciences-nsei-zyduslife-reports-010650605.html', 'site': 'finance', 'region': 'US', 'lang': 'en-US'}, 'metadata': {'editorsPick': False}, 'finance': {'premiumFinance': {'isPremiumNews': False, 'isPremiumFreeNews': False}}, 'storyline': None}",N/A,N/A,N/A,N/A,N/A,N/A
